IO Biotech Inc. (IOBT) NASDAQ
$1.73 - (-)
Market Cap: $113.97M
As of 03/28/24 04:00 PM EDT. Market closed.
IO Biotech Inc. (IOBT)
NASDAQ
$1.73
- (-)
Market Cap: $113.97M
As of 03/28/24 04:00 PM EDT. Market closed.
io biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of t cells that are specific for immune inhibitory molecules. io biotech has achieved a proven track record of progressing compounds to ... read more
io biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of t cells that are specific for immune inhibitory molecules. io biotech has achieved a proven track record of progressing compounds to the clinic, and has two lead immune modulating anti-cancer therapies targeting ido and pd-l1 in clinical development and several compounds finalizing preclinical phase. io biotech has an experienced management team within immuno-oncology fields and a world-class advisory board. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Novo Holdings A/S | 10% Owner | Feb 09, 2024 | Sale | $1.50 | 658,809 | 988,411 | 5,088,258 | Feb 13, 2024, 09:31 PM |
Burkavage Brian | Chief Accounting Officer | Nov 22, 2023 | Buy | $1.03 | 5,000 | 5,175 | 11,500 | Nov 24, 2023, 05:37 PM |
Burkavage Brian | Chief Accounting Officer | Nov 21, 2023 | Buy | $0.99 | 5,000 | 4,950 | 6,500 | Nov 24, 2023, 05:37 PM |
Elling Christian E | Director | Aug 09, 2023 | Option Exercise | $1.90 | 7,901,234 | 15,012,344 | 13,950,686 | Aug 11, 2023, 09:24 PM |
Lundbeckfond Invest A/S | Director | Aug 09, 2023 | Option Exercise | $1.90 | 7,901,234 | 15,012,344 | 13,950,686 | Aug 11, 2023, 09:22 PM |
Novo Holdings A/S | 10% Owner | Aug 09, 2023 | Buy | $2.03 | 2,469,135 | 4,999,999 | 5,707,467 | Aug 11, 2023, 04:31 PM |
Vivo Capital IX, LLC | 10% Owner | Aug 09, 2023 | Buy | $1.90 | 3,157,894 | 5,999,999 | 3,157,894 | Aug 10, 2023, 09:03 AM |
Zocca Mai-Britt | Chief Executive Officer | Aug 09, 2023 | Option Exercise | $1.90 | 37,037 | 70,370 | 37,391 | Aug 09, 2023, 08:43 PM |
Sullivan Amy | Chief Financial Officer | Aug 09, 2023 | Option Exercise | $1.90 | 49,382 | 93,826 | 74,382 | Aug 09, 2023, 08:41 PM |
Smith Devin Whittemore | General Counsel | Aug 09, 2023 | Option Exercise | $1.90 | 4,938 | 9,382 | 4,938 | Aug 09, 2023, 08:38 PM |
Sullivan Amy | Chief Financial Officer | Mar 17, 2023 | Buy | $2.32 | 25,000 | 58,017 | 25,000 | Mar 20, 2023, 05:35 PM |
HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 325,000 | 4,550,000 | 2,690,545 | Nov 12, 2021, 04:16 PM |
Malier Vanessa | Director | Nov 09, 2021 | Buy | $14.00 | 325,000 | 4,550,000 | 958,559 | Nov 12, 2021, 04:16 PM |
Vivo Capital IX, LLC | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 650,000 | 9,100,000 | 3,015,545 | Nov 12, 2021, 04:16 PM |
Andersson Claus A. | Director | Nov 09, 2021 | Buy | $14.00 | 75,000 | 1,050,000 | 1,791,490 | Nov 12, 2021, 04:16 PM |
Lundbeckfond Invest A/S | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 2,142,857 | 29,999,998 | 6,049,452 | Nov 12, 2021, 04:15 PM |
Nielsen Jack | Director | Nov 09, 2021 | Buy | $14.00 | 650,000 | 9,100,000 | 3,015,545 | Nov 12, 2021, 04:15 PM |
Novo Holdings A/S | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 325,000 | 4,550,000 | 3,277,932 | Nov 10, 2021, 07:04 PM |
Owner | Relationship | Date | Value($) |
Novo Holdings A/S | 10% Owner | 02/09/2024 | 988,411 |
Burkavage Brian | Chief Accounting Officer | 11/22/2023 | 5,175 |
Burkavage Brian | Chief Accounting Officer | 11/21/2023 | 4,950 |
Elling Christian E | Director | 08/09/2023 | 15,012,344 |
Lundbeckfond Invest A/S | Director | 08/09/2023 | 15,012,344 |
Novo Holdings A/S | 10% Owner | 08/09/2023 | 4,999,999 |
Vivo Capital IX, LLC | 10% Owner | 08/09/2023 | 5,999,999 |
Zocca Mai-Britt | Chief Executive Officer | 08/09/2023 | 70,370 |
Sullivan Amy | Chief Financial Officer | 08/09/2023 | 93,826 |
Smith Devin Whittemore | General Counsel | 08/09/2023 | 9,382 |
Sullivan Amy | Chief Financial Officer | 03/17/2023 | 58,017 |
HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 11/09/2021 | 4,550,000 |
Malier Vanessa | Director | 11/09/2021 | 4,550,000 |
Vivo Capital IX, LLC | 10% Owner | 11/09/2021 | 9,100,000 |
Andersson Claus A. | Director | 11/09/2021 | 1,050,000 |
Lundbeckfond Invest A/S | 10% Owner | 11/09/2021 | 29,999,998 |
Nielsen Jack | Director | 11/09/2021 | 9,100,000 |
Novo Holdings A/S | 10% Owner | 11/09/2021 | 4,550,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
VIVO CAPITAL, LLC | 6,173,439 | 0.95% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 88,900 | 0.00026% | 264.55% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 12,730 | 0% | No change | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View